# Capricor Therapeutics Takes Legal Action to Protect Patient Access to Deramiocel for Duchenne Muscular Dystrophy
Canonical URL: https://biopharmsignal.com/news/CAPR/capricor-therapeutics-takes-legal-action-to-protect-patient-access-to-deramiocel-for-duchenne-muscular-dystrophy
Ticker: CAPR
Company: Capricor Therapeutics
Source: Capricor Therapeutics
Published: 2026-05-07 21:00 EST
Original Source URL: https://www.capricor.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-06-26 14:02 EST — [Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/capricor-therapeutics-announces-fda-advisory-committee-meeting-to-review-bla-for-4de22ae1) — Source: Capricor Therapeutics
- 2026-06-26 13:05 EST — [Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference](https://biopharmsignal.com/news/CAPR/capricor-to-present-positive-five-year-hope-2-ole-data-and-hope-3-phase-3-result-4fe04208) — Source: Capricor Therapeutics
- 2026-06-08 13:25 EST — [Capricor Therapeutics to Present at Upcoming Investor Conferences](https://biopharmsignal.com/news/CAPR/capricor-therapeutics-to-present-at-upcoming-investor-conferences-17e93e26) — Source: Capricor Therapeutics
- 2026-05-29 01:55 EST — [Capricor Therapeutics Expands Commercial Leadership Team](https://biopharmsignal.com/news/CAPR/capricor-therapeutics-expands-commercial-leadership-team) — Source: Capricor Therapeutics
- 2026-05-12 20:05 EST — [Capricor Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update](https://biopharmsignal.com/news/CAPR/capricor-therapeutics-reports-first-quarter-2026-financial-results-and-provides-corporate-update) — Source: Capricor Therapeutics
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)